Sarcoidosis of the Skin as an Interdisciplinary Problem

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Sarcoidosis is a disease of unknown etiology characterized by the formation of epithelioid cell granulomas in several organs or tissues without caseous necrosis (fibrinoid necrosis may occur). With sarcoidosis, almost all organs and tissues can be affected, which determines the interdisciplinary nature of the problem. Skin sarcoidosis is one of the most common manifestations of systemic sarcoidosis. At the same time, the role of dermatologists in the diagnosis of sarcoidosis is exceptionally large, since skin lesions are often the key to the discovery of systemic sarcoidosis, which allows internists to purposefully and timely diagnose and treat lesions of internal organs. Skin rashes in patients with sarcoidosis may occur secondarily against the background of specific lesions of the lungs, intrathoracic nodes and other internal organs, however, skin sarcoidosis may also develop primarily. All forms of skin sarcoidosis may be the only manifestation of the disease, and it is impossible to distinguish clinically and histologically between skin changes in systemic sarcoidosis and skin lesions alone. Treatment of skin sarcoidosis often presents great difficulties and includes, depending on the prevalence and activity of the process, local (corticosteroids, tacrolimus) and systemic therapy (immunomodulators, immunosuppressors, TNF inhibitors).

Full Text

Restricted Access

About the authors

Alexey V. Samtsov

S.M. Kirov Military Medical Academy

Author for correspondence.
Email: avsamtsov@mail.ru
ORCID iD: 0000-0002-9458-0872
SPIN-code: 2287-5062

MD, PhD, Professor

Russian Federation, 6G Akademika Lebedeva str., 194044, Saint Petersburg

Evgeniy V. Kryukov

S.M. Kirov Military Medical Academy

Email: evgeniy.md@mail.ru
ORCID iD: 0000-0002-8396-1936
SPIN-code: 3900-3441

MD, PhD, Professor, Academician of the RAS

Russian Federation, 6G Akademika Lebedeva str., 194044, Saint Petersburg

References

  1. Besnier EН. Lupus pernio de la face, synovites fungeuses (scrofulo-tuberculeuses) symmetriques des extrémités supérieures. Ann Dermatol Syph. 1888;10:333–336.
  2. Tenneson M. Lupus pernio. Ann Dermatol Syph. 1892;3:1142–1144.
  3. Boeck C. Multiple benign sarkoid of the skin. Urinary Dis. 1899;12:543–550.
  4. Darier J, Roussy G. Un cas de tumeurs benignes multiples (sarcoides sous-cutanees ou tuberculides nodulaires hypodermiques). Ann Dermatol Syph. 1904;2:144–149.
  5. Darier J, Roussy G. Des sarcoides sous-cutanees. Contribtition a l’etude des tuberculides ou tuberculoses attenuees de l’hypoderme. Arch Med Exp Anat Path. 1906;18:1–59.
  6. Schaumann J. Sur le lupus pernio, mémoire présenté en November 1914 a la Société Francaise de Dermatologie et le Syphiligraphie pour le Prix Zambaco. Stockholm, 1934.
  7. Scadding JG, Mitchell DN. Historical survey: treatment. In: Sarcoidosis. 2nd ed. London: Chapman and Hall; 1985. P. 1–12.
  8. Caplan A, Rosenbach M, Imadojemu S. Cutaneous Sarcoidosis. Semin Respir Crit Care Med. 2020;41(5):689–699. doi: https://doi.org/10.1055/s-0040-1713130
  9. Rybicki BA, Maliarik MJ, Major M, et al. Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect. 1998;13(03):166–173.
  10. Nunes H, Bouvry D, Soler P, et al. Sarcoidosis. Orphanet J Rare Dis. 2007;2:46. doi: https://doi.org/10.1186/1750-1172-2-46
  11. Hillerdal G, Nöu E, Osterman K, et al. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. 1984;130(1):29–32. doi: https://doi.org/10.1164/arrd.1984.130.1.29
  12. Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145(3):234–241. doi: https://doi.org/10.1093/oxfordjournals.aje.a009096
  13. Brito-Zerón P, Sellarés J, Bosch X, et al. Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences. Clin Exp Rheumatol. 2016;34(3):380–388.
  14. Yamaguchi M, Hosoda Y, Sasaki R, et al. Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis. 1989;6(02):138–146.
  15. Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008;31(2):372–379. doi: https://doi.org/10.1183/09031936.00075307
  16. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–2165. doi: https://doi.org/10.1056/NEJMra071714
  17. Ungprasert P, Wetter DA, Crowson CS, et al. Epidemiology of cutaneous sarcoidosis, 1976–2013: a population-based study from Olmsted County, Minnesota. J Eur Acad Dermatol Venereol. 2016;30(10):1799–1804. doi: https://doi.org/10.1111/jdv.13760
  18. Samtsov AV. Cutaneous sarcoidosis. Int J Dermatol. 1992;31(6):385–391. doi: https://doi.org/10.1111/j.1365-4362.1992.tb02664.x
  19. Визель А.А., Визель И.Ю., Амиров H.Б. Эпидемиология саркоидоза в Российской Федерации // Вестник современной клинической медицины. — 2017. — Т. 10. – № 5. — С. 66–73. [Vizel’ AA, Vizel’ IYu, Amirov NB. Epidemiology of sarcoidosis in the Russian Federation. The Bulletin of Contemporary Clinical Medicine. 2017;10(5):66–73. (In Russ.)] doi: https://doi.org/10.20969/VSKM.2017.10(5).66-73
  20. Rybicki BA, Maliarik MJ, Poisson LM, et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med. 2003;167(3):444–449. doi: https://doi.org/10.1164/rccm.2112060
  21. Rybicki BA, Maliarik MJ, Poisson LM, et al. Sarcoidosis and granuloma genes: a family-based study in African-Americans. Eur Respir J. 2004;24(2):251–257. doi: https://doi.org/10.1183/09031936.04.00005904
  22. Grunewald J. HLA associations and Löfgren’s syndrome. Expert Rev Clin Immunol. 2012;8(1):55–62. doi: https://doi.org/10.1586/eci.11.76
  23. Fingerlin TE, Hamzeh N, Maier LA. Genetics of Sarcoidosis. Clin Chest Med. 2015;36(4):569–584. doi: https://doi.org/10.1016/j.ccm.2015.08.002
  24. Bindoli S, Dagan A, Torres-Ruiz JJ, et al. Sarcoidosis and autoimmunity: from genetic background to environmental factors. Isr Med Assoc J. 2016;18(3–4):197–202.
  25. Eishi Y. Etiologic aspect of sarcoidosis as an allergic endogenous infection caused by Propionibacterium acnes. Biomed Res Int. 2013;2013:935289. doi: https://doi.org/10.1155/2013/935289
  26. Oswald-Richter KA, Beachboard DC, Seeley EH, et al. Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL. J Clin Immunol. 2012;32(5):1129–1140. doi: https://doi.org/10.1007/s10875-012-9700-5
  27. Потекаев Н.С., Теплюк Н.П., Беричекидзе Т.Т., и др. Клинические варианты саркоидоза кожи // Клиническая дерматология и венерология. — 2012. — Т. 10. — № 6. — С. 88–94. [Potekaev NS, Tepliuk NP, Berichekidze TT, et al. Clinical types of cutaneous sarcoidosis. Klinicheskaya Dermatologiya i Venerologiya. 2012;10(6):88–94. (In Russ.)]
  28. Celada LJ, Hawkins C, Drake WP. The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis. Clin Chest Med. 2015;36(4):561–568. doi: https://doi.org/10.1016/j.ccm.2015.08.001
  29. Dickson M, Hernándes B, Marciano S, et al. Prevalence and characteristic of cutaneous sarcoidosis in Argentina. Int J Womens Dermatol. 2021;7(3):280–284. doi: https://doi.org/10.1016/j.ijwd.2021.01.014
  30. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р., и др. Саркоидоз: федеральные клинические рекомендации по диагностике и лечению // Пульмонология. — 2022. — Т. 32. — № 6. — С. 806–833. [Chuchalin AG, Avdeev SN, Aisanov ZR, et al. Sarcoidosis: federal clinical guidelines for diagnosis and treatment. PULMONOLOGIYA. 2022;32(6):806–833. (In Russ.)] doi: https://doi.org/10.18093/0869-0189-2022-32-6-806-833
  31. Callen JP. The presence of foreign bodies does not exclude the diagnosis of sarcoidosis. Arch Dermatol. 2001;137(4):485–486.
  32. Marcoval J, Mañá J, Moreno A, et al. Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis. Arch Dermatol. 2001;137(4):427–430.
  33. Marcoval J, Moreno A, Mañá J. Foreign bodies in cutaneous sarcoidosis. J Cutan Pathol. 2004;31(7):516. doi: https://doi.org/10.1111/j.0303-6987.2004.00225.x
  34. Baughman RP, Teirstein AS, Judson MA, et al.; Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10Pt1):1885–1889. doi: https://doi.org/10.1164/ajrccm.164.10.2104046
  35. Yanardağ H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med. 2003;97(8):978–982. doi: https://doi.org/10.1016/s0954-6111(03)00127-6
  36. Mañá J, Marcoval J, Rubio M, et al. Granulomatous cutaneous sarcoidosis: diagnosis, relationship to systemic disease, prognosis and treatment. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(4):268–281.
  37. Esteves TC, Aparicio G, Ferrer B, et al. Prognostic value of skin lesions in sarcoidosis: clinical and histopathological clues. Eur J Dermatol. 2015;25(6):556–562. doi: https://doi.org/10.1684/ejd.2015.2666
  38. Koneti J, Cherukuri SР, Gadde S, et al. Sarcoidosis and Its Dermatological Manifestations: A Narrative Review. Cureus. 2022;14(8):e28053. doi: https://doi.org/10.7759/cureus.28053
  39. James DG. Sarcoidosis. Postgrad Med J. 1984;60(701):234–241. doi: https://doi.org/10.1136/pgmj.60.701.234
  40. Ungprasert P, Wetter DA, Crowson CS, et al. Epidemiology of cutaneous sarcoidosis, 1976–2013: a population-based study from Olmsted County, Minnesota. J Eur Acad Dermatol Venereol. 2016;30(10):1799–1804. doi: https://doi.org/10.1111/jdv.13760
  41. Wanat K, Rosenbach M. Cutaneous Sarcoidosis. Clin Chest Med. 2015;36(4):685–702. doi: https://doi.org/10.1016/j.ccm.2015.08.010
  42. Mañá J, Marcoval J. Skin manifestations of sarcoidosis. Presse Med. 2012;41(6Pt2):e355–е374. doi: https://doi.org/10.1016/j.lpm.2012.02.046
  43. Yanardag H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med. 2003;97(8):978–982. doi: https://doi.org/10.1016/s0954-6111(03)00127-6
  44. Marcoval J, Mañá J, Rubio M. Specific cutaneous lesions in patients with systemic sarcoidosis: relationship to severity and chronicity of disease. Clin Exp Dermatol. 2011;36(7):739–745. doi: https://doi.org/10.1111/j.1365-2230.2011.04128.x
  45. Нефедьева Ю.В., Шамгунова М.В., Иванова В.O., и др. Клинический случай саркоидоза кожи // Tрудный пациент. — 2018. — Т. 16. — № 5. — С. 38–40. [Nefedyeva JV, Schamgunova MV, Ivanova VO, et al. Case Report of Sarcoidosis of the Skin. Difficult Patient. 2018;16(5): 38–40. (In Russ.)]
  46. Mañá J, Marcoval J, Rubio M, et al. Granulomatous cutaneous sarcoidosis: diagnosis, relationship to systemic disease, prognosis and treatment. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(4):268–281.
  47. Spiteri MA, Matthey F, Gordon T, et al. Lupus pernio: a clinico-radiological study of thirty-five cases. Br J Dermatol. 1985;112(3):315–322. doi: https://doi.org/10.1111/j.1365-2133.1985.tb04859.x
  48. Stagaki E, Mountford WK, Lackland DT, et al. The treatment of lupus pernio: results of 116 treatment courses in 54 patients. Chest. 2009;135(2):468–476. doi: https://doi.org/10.1378/chest.08-1347
  49. Ahmed I, Harshad SR. Subcutaneous sarcoidosis: is it a specific subset of cutaneous sarcoidosis frequently associated with systemic disease? J Am Acad Dermatol. 2006;54(1):55–60. doi: https://doi.org/10.1016/j.jaad.2005.10.001
  50. Marcoval J, Maña J, Moreno A, et al. Subcutaneous sarcoidosis — clinicopathological study of 10 cases. Br J Dermatol. 2005;153(4):790–794. doi: https://doi.org/10.1111/j.1365-2133.2005.06815.x
  51. Meyer-Gonzalez T, Suarez-Perez JA, Lopez-Navarro N, et al. Subcutaneous sarcoidosis: a predictor of systemic disease? Eur J Intern Med. 2011;22(6):e162–е163. doi: https://doi.org/10.1016/j.ejim.2011.07.005
  52. Banse-Kupin L, Pelachyk JM. Ichthyosiform sarcoidosis. Report of two cases and a review of the literature. J Am Acad Dermatol. 1987;17(4):616–620. doi: https://doi.org/10.1016/s0190-9622(87)70246-1
  53. Kauh YC, Goody HE, Luscombe HA. Ichthyosiform sarcoidosis. Arch Dermatol. 1978;114(1):100–101.
  54. Кирдаков Д.Ф., Фомин В.В., Потекаев Н.Н. Саркоидоз кожи: клинические варианты и прогностическое значение // Фарматека. — 2011. — № 18. [Kirdakov D, Fomin V, Potekaev N. Sarcoidosis of the skin. Clinical variants and prognosis. Pharmteca. 2011;18. (In Russ.)]
  55. Визель И.Ю., Визель А.А. Поражение кожи при саркоидозе. Эффективная фармакотерапия // Пульмонология и оториноларингология. — 2012. — № 4. — С. 28–30. [Vizel IYu, Vizel AA. Cutaneous sarcoidosis. Effective pharmacotherapy. Pulmonology and Otorhinolaryngology. 2015;6:28–30. (In Russ.)]
  56. Kelly AP. Ichthyosiform sarcoid. Arch Dermatol. 1978;114(10):1551–1552.
  57. Cather JC, Cohen PR. Ichthyosiform sarcoidosis. J Am Acad Dermatol. 1999;40(5Pt2):862–865.
  58. Sawhney M, Sharma S, Gera V, et al. Ichthyosiform sarcoidosis following chemotherapy of Hodgkin’s disease. Indian J Dermatol Venereol Leprol. 2003;69(3):220–222.
  59. Burgoyne JS, Wood MG. Psoriasiform sarcoidosis. Arch Dermatol. 1976;106(6):896–898.
  60. Sakemi H, Oiwa H. Psoriasiform plaques of sarcoidosis. Intern Med. 2009;48(5):391. doi: https://doi.org/10.2169/internalmedicine.48.1686
  61. Евдокимов Е.Ю., Смирнова Л.М., Голубев М.А. Псориазoформный саркоидоз кожи // Российский журнал кожных и венерических болезней. — 2019. — Т. 22. — № 1–2. — С. 11–14. [Evdokimov EYu, Smirnova LM, Golubev MA. Psoriasiform cutaneous sarcoidosis. Russian Journal of Skin and Venereal Diseases. 2019;22(1–2):11–14. (In Russ.)] doi: https://doi.org/10.17816/dv42930
  62. Nishizawa A, Igawa K, Teraki H, et al. Diffuse disseminated lichenoid-type cutaneous sarcoidosis mimicking erythroderma. Int J Dermatol. 2014;53(8):e369–е370. doi: https://doi.org/10.1111/ijd.12356
  63. Shmunes E, Lantis LR, Hurley HJ. Verrucose sarcoidosis. Arch Dermatol. 1970;102(6):665–669.
  64. Tomoda F, Oda Y, Takata M, et al. A rare case of sarcoidosis with bilateral leg lymphedema as an initial symptom. Am J Med Sci. 1999;318(6):413–414. doi: https://doi.org/10.1097/00000441-199912000-00008
  65. Kawaguchi M, Suzuki T. Nail dystrophy without bony involvement in a patient with chronic sarcoidosis. J Dermatol. 2014;41(2):194–195. doi: https://doi.org/10.1111/1346-8138.12365
  66. Bekkali N, Boui M. Nail dystrophy: a rare sign of sarcoidosis. Pan Afr Med J. 2014;19:6758. doi: https://doi.org/10.11604/pamj.2014.19.67.4988
  67. Ichiki Y, Kitajima Y. Ulcerative sarcoidosis: case report and review of the Japanese literature. Acta Derm Venereol. 2008;88(5):526–528. doi: https://doi.org/10.2340/00015555-0525
  68. Yoo SS, Mimouni D, Nikolskaia OV, et al. Clinicopathologic features of ulcerative-atrophic sarcoidosis. Int J Dermatol. 2004;43(2):108–112. doi: https://doi.org/10.1111/j.1365-4632.2004.01896.x
  69. Motswaledi MH, Khammissa RA, Jadwat Y, et al. Oral sarcoidosis: a case report and review of the literature. Aust Dent J. 2014;59(3):389–394. doi: https://doi.org/10.1111/adj.12196
  70. Bouaziz A, Le Scanff J, Chapelon-Abric C, et al. Oral involvement in sarcoidosis: report of 12 cases. QJM. 2012;105(8):755–767. doi: https://doi.org/10.1093/qjmed/hcs042
  71. Veien NK, Stahl D, Brodthagen H. Cutaneous sarcoidosis in Caucasians. J Am Acad Dermatol. 1987;16(3Pt1):534–540. doi: https://doi.org/10.1016/s0190-9622(87)70070-x
  72. Katta R, Nelson B, Chen D, et al. Sarcoidosis of the scalp: a case series and review of the literature. J Am Acad Dermatol. 2000;42(4):690–692.
  73. Katta R. Cutaneous sarcoidosis: a dermatologic masquerader. Am Fam Physician. 2002;65(8):1581–1584.
  74. Cho HR, Shah A, Hadi S. Systemic sarcoidosis presenting with alopecia of the scalp. Int J Dermatol. 2004;43(7):520–522. doi: https://doi.org/10.1111/j.1365-4632.2004.02144.x
  75. Douri T, Chawaf AZ, Alrefaee BA. Cicatricial alopecia due to sarcoidosis. Dermatol Online J. 2003;9(1):16.
  76. Снарская Е.С., Акопова К.В., Вакулишина О.А. Аннулярный саркоидоз Бека // Российский журнал кожных и венерических болезней. — 2013. — № 4. — С. 35–38. [Snarskaya ES, Akopova KV, Vakulishina OA. Boeck’s annular sarcoidosis. Russian Journal of Skin and Venereal Diseases. 2013;4:35–38. (In Russ.)]
  77. Грицкова И.А., Горбунов Ю.Г., Алферов К.И., и др. Редкий случай фолликулярного саркоидоза // Вестник дерматологии и венерологии. — 2022. — Т. 98. — № 1. — С. 58–63. [Gritskova IA, Gorbunov YuG, Alferov KI, et al. A rare case of follicular sarcoidosis. Vestnik Dermatologii i Venerologii. 2022;98(1):58–63. (In Russ.)] doi: https://doi.org/10.25208/vdv1295
  78. Тихоновская И.В., Лесничая О.В., Королькова Н.К., и др. Ангио-люпоидный саркоидоз кожи: случай из практики // Медицинские новости. — 2017. — № 12. — С. 38–40. [Tichonovsky IV, Lesnichaya OV, Korolcova NK, et al. Angiolipoidal sarcoidosis of the skin: a case from practice. Medical news. 2017;12:38–40. (In Russ.)]
  79. Antonovich DD, Callen JP. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol. 2005;141(7):869–872. doi: https://doi.org/10.1001/archderm.141.7.869
  80. Corbaux C, Fauconneau A, Doutre MS, et al. Systemic sarcoidosis revealed by sarcoidal granulomas on tattoo. J Eur Acad Dermatol Venereol. 2016;30(6):1045–1046. doi: https://doi.org/10.1111/jdv.13099
  81. Kluger N. Sarcoidosis on tattoos: a review of the literature from 1939 to 2011. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(2):86–102.
  82. Morales-Callaghan AM Jr, Aguilar-Bernier M Jr, Martínez-García G, et al. Sarcoid granuloma on black tattoo. J Am Acad Dermatol. 2006;55(5Suppl):S71–S73. doi: https://doi.org/10.1016/j.jaad.2005.12.022
  83. Post J, Hull P. Tattoo reactions as a sign of sarcoidosis. CMAJ. 2012;184(4):432. doi: https://doi.org/10.1503/cmaj.110696
  84. Marcoval J, Mañá J. Silicone granulomas and sarcoidosis. Arch Dermatol. 2005;141(7):904. doi: https://doi.org/10.1001/archderm.141.7.904-a
  85. Marcoval J, Moreno A, Mañá J. Subcutaneous sarcoidosis localised to sites of previous desensitizing injections. Clin Exp Dermatol. 2008;33(2):132–134. doi: https://doi.org/10.1111/j.1365-2230.2007.02571.x
  86. Marcoval J, Fanlo M, Penín RM, et al. Systemic sarcoidosis with specific cutaneous lesions located at insulin injection sites for diabetes mellitus. J Eur Acad Dermatol Venereol. 2014;28(9):1259–1260. doi: https://doi.org/10.1111/jdv.12338
  87. Marcoval J, Mañá J, Penín RM, et al. Sarcoidosis associated with cosmetic fillers. Clin Exp Dermatol. 2014;39(3):397–399. doi: https://doi.org/10.1111/ced.12262
  88. Karadağ A, Parish L, Sarcoidosis: A great imitator. Clin Dermatol. 2019;37(3): 240–254. doi: https://doi.org/10.1016/j.clindermatol.2019.01.005
  89. Самцов А.В., Илькович М.М., Потекаев Н.С. Саркоидоз. — M.: Binom; СПб.: Невский диалект, 2001. — 158 с. [Samtsov AV, Il’kovich MM, Potekaev NS. Sarcoidosis. Moscow: Binom; St. Petersburg: Nevsky dialect; 2001. 158 р. (In Russ.)].
  90. Сорокина Е.В., Владимирова Е.В., Ахматова Н.К., и др. Дифференциальная диагностика гранулематозных дерматозов без доказанной роли инфекционных агентов // Клиническая дерматология и венерология. — 2021. — Т. 20. — № 6. — С. 19–29. [Sorokina EV, Vladimirova EV, Achmatova NK, et al. Differential diagnosis of granulomatous dermatoses without proven infectious agents. Klinicheskaya Dermatologiya i Venerologiya. 2021;20(6):19–29. (In Russ.)] doi: https://doi.org/10.17116/klinderma20212006119
  91. English JC 3rd, Patel PJ, Greer KE. Sarcoidosis. J Am Acad Dermatol. 2001;44(5):725–743; quiz 744–6. doi: https://doi.org/10.1067/mjd.2001.114596
  92. Haimovic A, Sanchez M, Judson MA, et al. Sarcoidosis: a comprehensive review and update for the dermatologist: part II. Extracutaneous disease. J Am Acad Dermatol. 2012;66(5):719.e1–10; quiz 729–30. doi: https://doi.org/10.1016/j.jaad.2012.02.003
  93. Costabel U, Guzman J, Baughman RP. Systemic evaluation of a potential cutaneous sarcoidosis patient. Clin Dermatol. 2007;25(3):303–311. doi: https://doi.org/10.1016/j.clindermatol.2007.03.008
  94. Chen ES, Moller DR. Sarcoidosis — scientific progress and clinical challenges. Nat Rev Rheumatol. 2011;7(8):457–467. doi: https://doi.org/10.1038/nrrheum.2011.93
  95. Wanat K, Rosenbach M. Cutaneous Sarcoidosis. Clin Chest Med. 2015;36(4):685–702. doi: http://dx.doi.org/10.1016/j.ccm.2015.08.010
  96. Dai C, Shih S, Ansari A, et al. Biologic Therapy in the Treatment of Cutaneous Sarcoidosis: A Literature Review. Am J Clin Dermatol. 2019;20(3):409–422. doi: https://doi.org/10.1007/s40257-019-00428-8

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies